Login or Sign Up
Concord Biotech Ltd. News And Announcements
15:57 Aug 01
Concord Biotech Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Biotechnology
Concord Biotech Ltd.
Industry Biotechnology
15:57 Aug 01
Quality
68/100
High Financial Strength
Valuation
28/100
Expensive Valuation
Technical
33/100
Technically Bearish
Strength
10
Weakness
3
Opportunity
0
Threats
1
18.21K
Market Cap (Cr)
49.00
PE Ratio
10.20
Price to Book Ratio
37.65
RSI
30.96 %
Net Profit Margin
Download Our App On:
Back
OTP sent to your mobile number/email. Please enter it below to verify.
